Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Prime Medicine Inc (PRME)

Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 489,726
  • Shares Outstanding, K 120,031
  • Annual Sales, $ 0 K
  • Annual Income, $ -198,130 K
  • EBIT $ -200 M
  • EBITDA $ -198 M
  • 60-Month Beta 2.18
  • Price/Sales 707.60
  • Price/Cash Flow N/A
  • Price/Book 2.46

Options Overview Details

View History
  • Implied Volatility 160.03% ( -8.33%)
  • Historical Volatility 85.53%
  • IV Percentile 90%
  • IV Rank 39.06%
  • IV High 365.17% on 04/05/24
  • IV Low 28.53% on 08/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 392
  • Volume Avg (30-Day) 475
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 5,178
  • Open Int (30-Day) 9,032

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.43
  • Number of Estimates 6
  • High Estimate -0.35
  • Low Estimate -0.47
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +21.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.28 +24.39%
on 10/02/24
5.02 -18.73%
on 09/30/24
+0.62 (+17.92%)
since 09/27/24
3-Month
3.28 +24.39%
on 10/02/24
5.94 -31.31%
on 07/31/24
-1.49 (-26.75%)
since 07/29/24
52-Week
3.28 +24.39%
on 10/02/24
9.86 -58.62%
on 12/15/23
-1.51 (-27.01%)
since 10/27/23

Most Recent Stories

More News
12 High-Growth Stocks That Could Deliver Parabolic Returns

These 12 innovative companies could deliver exponential returns over the next quarter century.

NVDA : 141.25 (+0.52%)
NVTS : 2.85 (+2.52%)
VRTX : 470.36 (-1.26%)
RKLB : 11.47 (+1.87%)
LUNR : 8.32 (+1.22%)
SERV : 11.68 (-1.02%)
ACHR : 3.36 (-1.47%)
TSLA : 259.52 (-1.14%)
CRSP : 48.94 (-1.55%)
SOUN : 6.01 (-1.80%)
APLD : 7.87 (-4.84%)
TM : 176.03 (-0.34%)
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

PRME : 4.08 (-3.09%)
Why I Keep Buying These 14 Incredible Growth Stocks

This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries.

NVDA : 141.25 (+0.52%)
NVTS : 2.85 (+2.52%)
RKLB : 11.47 (+1.87%)
KTOS : 24.19 (-0.04%)
LUNR : 8.32 (+1.22%)
ASPN : 18.23 (-6.37%)
TSM : 196.94 (+1.16%)
ACHR : 3.36 (-1.47%)
CRSP : 48.94 (-1.55%)
GE : 174.05 (-0.75%)
JOBY : 5.01 (-4.93%)
PRME : 4.08 (-3.09%)
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings

PRME : 4.08 (-3.09%)
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday

Changes are afoot at the company, and investors welcomed them.

PRME : 4.08 (-3.09%)
BMY : 52.50 (-0.27%)
2 Growth Stocks That Could Make You Richer

Discover two cutting-edge growth stocks that could revolutionize medicine and space exploration.

PRME : 4.08 (-3.09%)
RKLB : 11.47 (+1.87%)
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 48.41 (+0.02%)
NTLA : 14.99 (-8.26%)
PRME : 4.08 (-3.09%)
BEAM : 22.17 (-0.81%)
XBI : 98.56 (+0.07%)
WFC : 65.30 (-0.47%)
VKTX : 73.35 (-1.57%)
CRSP : 48.94 (-1.55%)
ABBV : 189.45 (-0.12%)
AMGN : 316.00 (-0.37%)
BMY : 52.50 (-0.27%)
GILD : 88.08 (-0.77%)
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio

Alphabet may have strong insight into both company's industries.

MSFT : 431.95 (+1.26%)
GOOG : 171.14 (+1.66%)
GOOGL : 169.68 (+1.78%)
GTLB : 54.73 (+1.58%)
PRME : 4.08 (-3.09%)
2 Magnificent Growth Stocks With Room to Run

These deeply undervalued growth stocks could be big winners for patient shareholders.

PRME : 4.08 (-3.09%)
TLRY : 1.7100 (-1.16%)
Better Growth Stock: Archer Aviation or Prime Medicine?

Which of these innovation-themed growth stocks is the better buy?

VRTX : 470.36 (-1.26%)
CRSP : 48.94 (-1.55%)
ACHR : 3.36 (-1.47%)
PRME : 4.08 (-3.09%)

Business Summary

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 4.55
2nd Resistance Point 4.38
1st Resistance Point 4.23
Last Price 4.08
1st Support Level 3.92
2nd Support Level 3.75
3rd Support Level 3.60

See More

52-Week High 9.86
Fibonacci 61.8% 7.35
Fibonacci 50% 6.57
Fibonacci 38.2% 5.79
Last Price 4.08
52-Week Low 3.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar